EP2672986
Frostþurrkaðar samsetningar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
9.2.2012EP published:
18.3.2020EP application number:
12744782.9
EP translation filed:
4.5.2020Grant published:
15.5.2020EPO information:
European Patent Register
Max expiry date:
8.2.2032Expiry date:
8.2.2025
Title:
LYOPHILIZED FORMULATIONS
Timeline
Today
9.2.2012EP application
18.3.2020EP Publication
4.5.2020Translation submitted
15.5.2020Registration published
8.2.2025Expires
Owner
Name:
GlaxoSmithKline LLCAddress:
251 Little Falls Drive, Wilmington, DE 19808, US
Inventor
Name:
KRANZ, JamesAddress:
King Of Prussia, PA 19406, US
Name:
RINELLA, JosephAddress:
King Of Prussia, PA 19406, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161440918 PDate:
9.2.2011Country:
US
Classification
Categories:
A61K 38/26, A61K 38/16, A61K 39/395, C07K 16/22, C07K 16/24, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 13.1.2021
Expires: 8.2.2022
Payer: Örn Þór slf.
Number: 11
Paid: 19.1.2022
Expires: 8.2.2023
Payer: Patice ehf.
Number: 12
Paid: 19.1.2023
Expires: 8.2.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 23.1.2024
Expires: 8.2.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 23.1.2024
Expires: 8.2.2025
Payer: Árnason Faktor ehf.